Flowflex COVID-19 (ART) has been authorised by HSA for self-testing

The Flowflex COVID-19 Antigen Rapid Test (ART) is authorised for use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR). The tests are meant to be used by consumers, no doctor’s prescription is required for their purchase. Here is a quick overview of how it works. For more information, please click here.

Self-Testing approval by HSA
• Pre-market approval by HSA
• FDA-EUA Approval
• CE-Mark for self-testing

With regular testing at home, you and your family can know your status so you can take action to help stop the spread of COVID-19. The kits are available to purchase for all consumers. Buy the test today.

Consumers can refer to MOH’s guidelines on COVID-19 self-testing to ensure the correct use and appropriate follow-up actions based on the results of the self-testing.

share post: